Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 611 publications

Noninsulin drugs for type 2 diabetes.

Noninsulin drugs for type 2 diabetes.

Journal: The Medical letter on drugs and therapeutics
Published: November 19, 2025

Cardiovascular Sequel in Type-2 Diabetes Mellitus Patients on Various Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systemic Review and Meta-Analysis.

Cardiovascular Sequel in Type-2 Diabetes Mellitus Patients on Various Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systemic Review and Meta-Analysis.

Journal: Cureus
Published: October 14, 2025

Efficacy and Safety of Vildagliptin Versus Other Dipeptidyl Peptidase 4 (DPP-4) Inhibitors in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.

Efficacy and Safety of Vildagliptin Versus Other Dipeptidyl Peptidase 4 (DPP-4) Inhibitors in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.

Journal: Cureus
Published: September 01, 2025

Exploring the Evidence for Personalized Pharmacotherapy in Type 2 Diabetes-A Systematic Review.

Exploring the Evidence for Personalized Pharmacotherapy in Type 2 Diabetes-A Systematic Review.

Journal: Journal of personalized medicine
Published: August 29, 2025

Alogliptin Mitigates Methotrexate-Induced Nephrotoxicity in a Rat Model: Antagonizing Oxidative Stress, Inflammation and Apoptosis.

Alogliptin Mitigates Methotrexate-Induced Nephrotoxicity in a Rat Model: Antagonizing Oxidative Stress, Inflammation and Apoptosis.

Journal: International journal of molecular sciences
Published: August 07, 2025

Comparative effectiveness of metformin and alogliptin combination therapy versus metformin monotherapy in patients with type 2 diabetes: an emulated target trial.

Comparative effectiveness of metformin and alogliptin combination therapy versus metformin monotherapy in patients with type 2 diabetes: an emulated target trial.

Journal: BMC endocrine disorders
Published: August 05, 2025

Alogliptin repositioning confers protection against diclofenac-induced liver injury by inhibiting TLR4/NF-κB, ROS/TXNIP, and NLRP3 inflammasome-mediated pyroptosis in rats.

Alogliptin repositioning confers protection against diclofenac-induced liver injury by inhibiting TLR4/NF-κB, ROS/TXNIP, and NLRP3 inflammasome-mediated pyroptosis in rats.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: July 26, 2025

Effect of Oral Hypoglycaemic Agents on Carotid Artery Intima-Media Thickness in Patients With Cardiovascular Disease and/or Diabetes-A Systematic Review.

Effect of Oral Hypoglycaemic Agents on Carotid Artery Intima-Media Thickness in Patients With Cardiovascular Disease and/or Diabetes-A Systematic Review.

Journal: Endocrinology, diabetes & metabolism
Published: July 10, 2025

Dipeptidyl Peptidase-4 Inhibitors Associated with Lower Psoriatic Disease Risk in Type 2 Diabetes: A 13-Year Nationwide Cohort Study with Mechanistic Validation.

Dipeptidyl Peptidase-4 Inhibitors Associated with Lower Psoriatic Disease Risk in Type 2 Diabetes: A 13-Year Nationwide Cohort Study with Mechanistic Validation.

Journal: Acta dermato-venereologica
Published: July 08, 2025

Efficacy and safety of pioglitazone versus dapagliflozin as an add-on to metformin and alogliptin combination therapy: the EPIDOTE study.

Efficacy and safety of pioglitazone versus dapagliflozin as an add-on to metformin and alogliptin combination therapy: the EPIDOTE study.

Journal: Scientific reports
Published: June 05, 2025

Ultrasensitive detection of alogliptin via fluorescence quenching of terbium-doped carbon quantum dots: mechanistic investigation, Box-Behnken optimization and analytical evaluation.

Ultrasensitive detection of alogliptin via fluorescence quenching of terbium-doped carbon quantum dots: mechanistic investigation, Box-Behnken optimization and analytical evaluation.

Journal: RSC advances
Published: April 19, 2025

Fixed-dose combinations of hypoglycemic drugs: potential of alogliptin/pioglitazone in type 2 diabetes mellitus: a review

Fixed-dose combinations of hypoglycemic drugs: potential of alogliptin/pioglitazone in type 2 diabetes mellitus: a review

Journal: Terapevticheskii arkhiv
Published: March 31, 2025
Showing 1-12 of 611

Last Updated: 01/07/2026